Many new and reemerging pathogenic organisms, such as bacteria, virus, fungi, and parasites, have continued to challenge the public health for long time. Immunotherapy and precision treatments have emerged as powerful tools in treatment of these infectious diseases. The key insight of immunotherapy is that a patient’s own immune system could be harnessed to recognize and destroy these pathogenic organisms. Precision treatments consider individual differences in a patient’s genes, environments, and lifestyles. Thanks to the global efforts, many strategies have been developed to save or extend the lives of patients suffering from infectious diseases. However, strains of common microbes have continued to develop resistance to the drugs and other newly emerging pathogens have become life-threatening. Breakthroughs in immunotherapy and precision treatments would provide new opportunities for accelerated progress against infectious diseases.
Despite the big efforts that are being made to treat or cure infectious disease in the past few decades, some pathogenic microbes have evolved advanced strategies against drugs treatments and evaded or attacked the immune system. Current available drugs or treatments are neither insufficient or exhibit limited efficacy against pathogens, thus there is an urgent need for new drugs with improved efficacy or novel therapies to combat infectious disease.
With effective antimicrobial therapies and precision treatments, we can provide lifesaving treatment especially during conditions like lung infection, surgery, other organ infections, and cancer treatment. In this context, the breakthroughs in immunotherapies and precision treatment against infectious diseases would be of extreme interest to the researchers and biomedical professionals. Therefore, the goal of this Research Topic is to present various novel therapeutic strategies that are available to combat pathogens that causing infectious disease.
We welcome submissions of Original Research, Case report, Perspectives, Opinion, Review and Mini Review articles, encompassing basic science, clinical science and public health research that focus on but are not limited to:
1) Advances in immunotherapies of infectious diseases (bacterial, viral and fungal infection) including vaccines, T-cell engineering immunotherapy, Antibody/Ligand-based therapies, cytokine therapy, checkpoint inhibition and other emerging immunotherapies.
2) Novel research in precision treatment against infectious diseases such as development of target drug, precision epidemiology, individual-level treatment, molecular diagnosis, host-directed therapies, emerging screening methods and so on.
3) New technologies and tools for reducing costs and increasing efficiency/accuracy for infectious diseases therapy.
4) Novel animal models of infectious diseases in immunotherapies and precision treatment.
5) Research and cases limited to immunotherapies with a strong pharmacological and clinical focus in the therapy of infectious diseases
Chen Li, Ph.D student, in the role of Coordinator contributed to developing the Research Topic description.
Many new and reemerging pathogenic organisms, such as bacteria, virus, fungi, and parasites, have continued to challenge the public health for long time. Immunotherapy and precision treatments have emerged as powerful tools in treatment of these infectious diseases. The key insight of immunotherapy is that a patient’s own immune system could be harnessed to recognize and destroy these pathogenic organisms. Precision treatments consider individual differences in a patient’s genes, environments, and lifestyles. Thanks to the global efforts, many strategies have been developed to save or extend the lives of patients suffering from infectious diseases. However, strains of common microbes have continued to develop resistance to the drugs and other newly emerging pathogens have become life-threatening. Breakthroughs in immunotherapy and precision treatments would provide new opportunities for accelerated progress against infectious diseases.
Despite the big efforts that are being made to treat or cure infectious disease in the past few decades, some pathogenic microbes have evolved advanced strategies against drugs treatments and evaded or attacked the immune system. Current available drugs or treatments are neither insufficient or exhibit limited efficacy against pathogens, thus there is an urgent need for new drugs with improved efficacy or novel therapies to combat infectious disease.
With effective antimicrobial therapies and precision treatments, we can provide lifesaving treatment especially during conditions like lung infection, surgery, other organ infections, and cancer treatment. In this context, the breakthroughs in immunotherapies and precision treatment against infectious diseases would be of extreme interest to the researchers and biomedical professionals. Therefore, the goal of this Research Topic is to present various novel therapeutic strategies that are available to combat pathogens that causing infectious disease.
We welcome submissions of Original Research, Case report, Perspectives, Opinion, Review and Mini Review articles, encompassing basic science, clinical science and public health research that focus on but are not limited to:
1) Advances in immunotherapies of infectious diseases (bacterial, viral and fungal infection) including vaccines, T-cell engineering immunotherapy, Antibody/Ligand-based therapies, cytokine therapy, checkpoint inhibition and other emerging immunotherapies.
2) Novel research in precision treatment against infectious diseases such as development of target drug, precision epidemiology, individual-level treatment, molecular diagnosis, host-directed therapies, emerging screening methods and so on.
3) New technologies and tools for reducing costs and increasing efficiency/accuracy for infectious diseases therapy.
4) Novel animal models of infectious diseases in immunotherapies and precision treatment.
5) Research and cases limited to immunotherapies with a strong pharmacological and clinical focus in the therapy of infectious diseases
Chen Li, Ph.D student, in the role of Coordinator contributed to developing the Research Topic description.
